Viewing Study NCT00950105


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2025-12-30 @ 9:22 PM
Study NCT ID: NCT00950105
Status: COMPLETED
Last Update Posted: 2012-08-23
First Post: 2009-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)
Sponsor: Ferring Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module